If bavi plays so well, if all of big pharma needs/wants bavi? Why no interest in stock no back to pre-btd price below $140 and heading g for test of high $1.20's. The bavi is supreme rhetoric is getting silly!
With all due respect, isn't it necessary to take blood/biopsies from the beginning of the clinical trial in order to use them as surrogate endpoints? SK has sad repeatedly they would not be part of the phIII.